DE60301886D1 - Verwendung von uk114 für die behandlung von leishmaniasis - Google Patents

Verwendung von uk114 für die behandlung von leishmaniasis

Info

Publication number
DE60301886D1
DE60301886D1 DE60301886T DE60301886T DE60301886D1 DE 60301886 D1 DE60301886 D1 DE 60301886D1 DE 60301886 T DE60301886 T DE 60301886T DE 60301886 T DE60301886 T DE 60301886T DE 60301886 D1 DE60301886 D1 DE 60301886D1
Authority
DE
Germany
Prior art keywords
leishmaniasis
treatment
ubiquitin
humans
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60301886T
Other languages
English (en)
Inventor
Antonio Salvaggio
Ferdinando Nicoletti
Battesimo Macri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMAPRODUCTS UK Ltd
Original Assignee
PHARMAPRODUCTS UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMAPRODUCTS UK Ltd filed Critical PHARMAPRODUCTS UK Ltd
Application granted granted Critical
Publication of DE60301886D1 publication Critical patent/DE60301886D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE60301886T 2002-06-04 2003-05-27 Verwendung von uk114 für die behandlung von leishmaniasis Expired - Lifetime DE60301886D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002MI001205A ITMI20021205A1 (it) 2002-06-04 2002-06-04 Uso di proteine per il trattamento della leishmaniosi
PCT/EP2003/005551 WO2003101477A1 (en) 2002-06-04 2003-05-27 Use of uk114 in the treatment of leishmaniasis

Publications (1)

Publication Number Publication Date
DE60301886D1 true DE60301886D1 (de) 2006-02-23

Family

ID=11450033

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60301886T Expired - Lifetime DE60301886D1 (de) 2002-06-04 2003-05-27 Verwendung von uk114 für die behandlung von leishmaniasis

Country Status (10)

Country Link
US (1) US20060100142A1 (de)
EP (1) EP1511510B1 (de)
JP (1) JP2005529932A (de)
AT (1) ATE306279T1 (de)
AU (1) AU2003238407A1 (de)
BR (1) BR0311596A (de)
DE (1) DE60301886D1 (de)
IT (1) ITMI20021205A1 (de)
MX (1) MXPA04012050A (de)
WO (1) WO2003101477A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024074870A1 (es) * 2022-10-06 2024-04-11 Instituto Politecnico Nacional Composición veterinaria de péptidos para inmunoterapia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290828B1 (it) * 1997-03-25 1998-12-11 Zetesis Spa Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche
IT1298442B1 (it) * 1998-02-24 2000-01-10 Zetesis Spa Composizioni orali a basso dosaggio di proteine citotossiche
ITMI991384A1 (it) * 1999-06-22 2000-12-22 Zetesis Spa Uso della proteina uk 114 per inibire il rigetto dei trapianti d'organo

Also Published As

Publication number Publication date
ITMI20021205A0 (it) 2002-06-04
US20060100142A1 (en) 2006-05-11
EP1511510B1 (de) 2005-10-12
AU2003238407A1 (en) 2003-12-19
ATE306279T1 (de) 2005-10-15
ITMI20021205A1 (it) 2003-12-04
BR0311596A (pt) 2005-04-26
WO2003101477A1 (en) 2003-12-11
MXPA04012050A (es) 2005-09-08
JP2005529932A (ja) 2005-10-06
EP1511510A1 (de) 2005-03-09

Similar Documents

Publication Publication Date Title
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
CY1115745T1 (el) Συνθεσεις και μεθοδοι για αντιμετωπιση ή προληψη σχετιζομενης με οξαλικα νοσου
BR0011838A (pt) Elementos misturadores estáticos empilhados
ATE417037T1 (de) Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
CY1113306T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
DK1408984T3 (da) Organofosforforbindelser til aktivering af gamma/delta T celler
DE60325498D1 (de) 1-acyl-pyrrolidin-derivate für die behandlung von viralen infektionen
NO20055741L (no) Nye kjemiske forbindelser
DE60239558D1 (de) Kombinationen für die behandlung von immun-entzündlichen erkrankungen
ATE422498T1 (de) Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems
DK1539724T3 (da) Aminobenzothiazolforbindelser med NOS-inhiberende aktivitet
ATE413399T1 (de) Morpholinyl-harnstoff-derivative fuer die behandlung von krankheiten verbunden mit entzuendlichen prozessen
DE60325353D1 (de) Behandlung von mukositis
DE602005013650D1 (de) Proteinhydrolysat zur behandlung von müdigkeit
DE60230455D1 (de) Natürliche verbindung für die behandlung von diabetes, deren herstellung und verwendung
DE60325496D1 (de) Verwendung von dihydroimidazolonen zur behandlung von epilepsie bei hunden
ATE406171T1 (de) Aplidine zur behandlung von multiplem myelom
DE60301886D1 (de) Verwendung von uk114 für die behandlung von leishmaniasis
DE50308032D1 (de) Isoliertes fluoreszierendes protein aus clytia gregaria cgfp, sowie dessen verwendung
DE602005013805D1 (de) Verwendung von il-17f zur behandlung und/oder prävention von neurologischen erkrankungen
ATE277924T1 (de) Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression
DE60316316D1 (de) Verbesserung bei fässern zur behandlung von fellen, häuten und leder
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen

Legal Events

Date Code Title Description
8332 No legal effect for de